Potassium Channel Blockers
- Name
- Potassium Channel Blockers
- Accession Number
- DBCAT000519 (DBCAT004105)
- Description
A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.
- Drugs
Drug Drug Description Dalfampridine A potassium channel blocker used for the improvement of motor function in patients with multiple sclerosis (MS). Dofetilide A class III antiarrhythmic drug used for the maintenance of normal sinus rhythm and cardioversion in cases of atrial fibrillation and atrial flutter. Amiodarone A class III antiarrhythmic indicated for the treatment of recurrent hemodynamically unstable ventricular tachycardia and recurrent ventricular fibrillation. Tetraethylammonium Tetraethylammonium is an experimental drug with no approved indication. Linopirdine Not Annotated Nateglinide A meglitinide used to treat non insulin dependent diabetes mellitus. Repaglinide A antihyperglycemic used to improve glycemic control in diabetes. Amifampridine A voltage gated potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome. - Drugs & Drug Targets